Q2 2023 · 13F-HR
Data Collective IV GP, LLCholdings as filed
Filed 2023-08-14 · accession 0001104659-23-090910
$135.1M
Reported value
6
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 30049H102 | EVLV | Evolv Technologies Holdings, Inc. | $63.6M | 47.1% | 10,601,281 | Common | SOLE |
| 75629V104 | RXRX | Recursion Pharmaceuticals, Inc. | $44.4M | 32.9% | 5,941,120 | Common | SOLE |
| 773122106 | — | Rocket Lab USA, Inc. | $17.6M | 13.0% | 2,929,350 | Common | SOLE |
| 29079J202 | — | Embark Technology, Inc. | $9.1M | 6.75% | 3,186,007 | Common | SOLE |
| 60255C885 | BRD1EUR | Mind Medicine (MindMed) Inc. | $358,250 | 0.27% | 100,350 | Common | SOLE |
| G76279101 | ROIV | Roivant Sciences Ltd. | $39,060 | 0.03% | 3,875 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.